ScreenerHero
BIMbioMerieux S.A.
EPA · FR · Healthcare · Diagnostics & Research · biomerieux.com
73.60EUR-0.81%Mkt Cap: 9.51B $P/E: 19.03

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It ope…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD
RDNT
RadNet, Inc.
$5.94BUSD

Key Statistics

Company
Market Cap9.51B $
Enterprise Value9.29B $
Revenue (TTM)4.34B $
Gross Profit2.51B $
Net Income (TTM)432.07M $
Revenue/Share36.86 USD
Last Price73.60 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14.6K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0013280286
Valuation
P/E (Trailing)19.03
P/E (Forward)15.99
PEG1.82
EV/EBITDA8.13
EV/Revenue2.14
P/S2.20
P/B2.04
EPS (TTM)3.90
EPS (Forward)4.66
52W Range
65.6013% of range127.10
52W High127.10 EUR
52W Low65.60 EUR
Profitability
Gross Margin56.73%
Oper. Margin15.23%
EBITDA Margin26.33%
Profit Margin9.77%
ROE9.69%
ROA7.13%
Growth
Revenue Growth-3.90%
Earnings Growth41.90%
Cash Flow & Leverage
Operating CF856.96M $
CapEx (TTM)364.46M $
FCF Margin14.77%
FCF Yield6.73%
Net Debt-256.41M $
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.11
Current Ratio2.30
Quick Ratio1.44
Book Value/Sh36.51 EUR
Cash/Share5.588 EUR
Dividends
Fwd Div Rate0.9800 EUR
Trail. Div Rate0.9800 EUR
Div. Yield1.34%
5Y Avg Yield0.84%
Payout Ratio25.13%
Ex-Div DateJun 9, 2026
Pay Date—
Splits
Last Split3:1
Split DateSep 20, 2017
Analyst Consensus
Rating—
Target (Mean)79.04 EUR
Upside (mean)+7.4%
Target Range64.00 EUR – 100.00 EUR
€64.00+7.4% to mean€100.00
# Analysts14
Ownership
Shares Out.117.95M
Float40.02M
Insiders66.46%
Institutions16.86%
Technical
SMA 5070.72 (+4.1%)
SMA 20088.15 (-16.5%)
Beta0.57
S&P 52W Chg18.16%
Avg Vol (30d)73.42K
Avg Vol (10d)120.92K
Technical Indicators
RSI (14)58.5
MACD0.5845
MACD Signal0.5128
MACD Hist.+0.0716
BB Upper75.03 EUR
BB Middle72.49 EUR
BB Lower69.96 EUR
BB Width7.00%
ATR (14)1.655 EUR
Vol Ratio (20d)0.60x